CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 808 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,680 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Finance and Administration gave up 1,685 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 5,611 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes VP, Finance and Administration gave up 2,739 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 48,518 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,787 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,773 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes VP, Finance and Administration gave up 1,557 shares (to pay taxes)
Page 17 of 33 · 652 filings